Organ-on-a-Chip Market Size to Hit USD 3,448.33 Million by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Organ-on-a-Chip Market

5.1. COVID-19 Landscape: Organ-on-a-Chip Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Organ-on-a-Chip Market, By Organ Type

8.1. Organ-on-a-Chip Market Revenue and Volume Forecast, by Organ Type

8.1.1. Liver-on-a-Chip

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Lung-on-a-Chip

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Heart-on-a-Chip

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Kidney-on-a-Chip

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Brain-on-a-Chip

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Intestine-on-a-Chip

8.1.6.1. Market Revenue and Volume Forecast

8.1.7. Skin-on-a-Chip

8.1.7.1. Market Revenue and Volume Forecast

8.1.8. Multi-Organ / Body-on-a-Chip

8.1.8.1. Market Revenue and Volume Forecast

8.1.9. Others

8.1.9.1. Market Revenue and Volume Forecast

Chapter 9. Global Organ-on-a-Chip Market, By Offering

9.1. Organ-on-a-Chip Market Revenue and Volume Forecast, by Offering

9.1.1. Devices / Platforms

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Consumables & Reagents

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Software & Analytical Tools

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Services

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Organ-on-a-Chip Market, By Application

10.1. Organ-on-a-Chip Market Revenue and Volume Forecast, by Application

10.1.1. Drug Discovery & Development

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Toxicology Research

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Disease Modeling

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Personalized Medicine

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Regenerative Medicine Research

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Organ-on-a-Chip Market, By End User

11.1. Organ-on-a-Chip Market Revenue and Volume Forecast, by End User

11.1.1. Pharmaceutical & Biotechnology Companies

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Academic & Research Institutes

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. CROs (Contract Research Organizations)

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global Organ-on-a-Chip Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Organ Type

12.1.2. Market Revenue and Volume Forecast, by Offering

12.1.3. Market Revenue and Volume Forecast, by Application

12.1.4. Market Revenue and Volume Forecast, by End User

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Organ Type

12.1.5.2. Market Revenue and Volume Forecast, by Offering

12.1.5.3. Market Revenue and Volume Forecast, by Application

12.1.5.4. Market Revenue and Volume Forecast, by End User

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Organ Type

12.1.6.2. Market Revenue and Volume Forecast, by Offering

12.1.6.3. Market Revenue and Volume Forecast, by Application

12.1.6.4. Market Revenue and Volume Forecast, by End User

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Organ Type

12.2.2. Market Revenue and Volume Forecast, by Offering

12.2.3. Market Revenue and Volume Forecast, by Application

12.2.4. Market Revenue and Volume Forecast, by End User

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Organ Type

12.2.5.2. Market Revenue and Volume Forecast, by Offering

12.2.5.3. Market Revenue and Volume Forecast, by Application

12.2.5.4. Market Revenue and Volume Forecast, by End User

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Organ Type

12.2.6.2. Market Revenue and Volume Forecast, by Offering

12.2.6.3. Market Revenue and Volume Forecast, by Application

12.2.6.4. Market Revenue and Volume Forecast, by End User

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Organ Type

12.2.7.2. Market Revenue and Volume Forecast, by Offering

12.2.7.3. Market Revenue and Volume Forecast, by Application

12.2.7.4. Market Revenue and Volume Forecast, by End User

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Organ Type

12.2.8.2. Market Revenue and Volume Forecast, by Offering

12.2.8.3. Market Revenue and Volume Forecast, by Application

12.2.8.4. Market Revenue and Volume Forecast, by End User

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Organ Type

12.3.2. Market Revenue and Volume Forecast, by Offering

12.3.3. Market Revenue and Volume Forecast, by Application

12.3.4. Market Revenue and Volume Forecast, by End User

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Organ Type

12.3.5.2. Market Revenue and Volume Forecast, by Offering

12.3.5.3. Market Revenue and Volume Forecast, by Application

12.3.5.4. Market Revenue and Volume Forecast, by End User

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Organ Type

12.3.6.2. Market Revenue and Volume Forecast, by Offering

12.3.6.3. Market Revenue and Volume Forecast, by Application

12.3.6.4. Market Revenue and Volume Forecast, by End User

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Organ Type

12.3.7.2. Market Revenue and Volume Forecast, by Offering

12.3.7.3. Market Revenue and Volume Forecast, by Application

12.3.7.4. Market Revenue and Volume Forecast, by End User

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Organ Type

12.3.8.2. Market Revenue and Volume Forecast, by Offering

12.3.8.3. Market Revenue and Volume Forecast, by Application

12.3.8.4. Market Revenue and Volume Forecast, by End User

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Organ Type

12.4.2. Market Revenue and Volume Forecast, by Offering

12.4.3. Market Revenue and Volume Forecast, by Application

12.4.4. Market Revenue and Volume Forecast, by End User

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Organ Type

12.4.5.2. Market Revenue and Volume Forecast, by Offering

12.4.5.3. Market Revenue and Volume Forecast, by Application

12.4.5.4. Market Revenue and Volume Forecast, by End User

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Organ Type

12.4.6.2. Market Revenue and Volume Forecast, by Offering

12.4.6.3. Market Revenue and Volume Forecast, by Application

12.4.6.4. Market Revenue and Volume Forecast, by End User

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Organ Type

12.4.7.2. Market Revenue and Volume Forecast, by Offering

12.4.7.3. Market Revenue and Volume Forecast, by Application

12.4.7.4. Market Revenue and Volume Forecast, by End User

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Organ Type

12.4.8.2. Market Revenue and Volume Forecast, by Offering

12.4.8.3. Market Revenue and Volume Forecast, by Application

12.4.8.4. Market Revenue and Volume Forecast, by End User

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Organ Type

12.5.2. Market Revenue and Volume Forecast, by Offering

12.5.3. Market Revenue and Volume Forecast, by Application

12.5.4. Market Revenue and Volume Forecast, by End User

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Organ Type

12.5.5.2. Market Revenue and Volume Forecast, by Offering

12.5.5.3. Market Revenue and Volume Forecast, by Application

12.5.5.4. Market Revenue and Volume Forecast, by End User

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Organ Type

12.5.6.2. Market Revenue and Volume Forecast, by Offering

12.5.6.3. Market Revenue and Volume Forecast, by Application

12.5.6.4. Market Revenue and Volume Forecast, by End User

Chapter 13. Company Profiles

13.1. Nortis Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerOrgan Typeance

13.1.4. Recent Initiatives

13.2. AxoSim Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerOrgan Typeance

13.2.4. Recent Initiatives

13.3. Organovo Holdings Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerOrgan Typeance

13.3.4. Recent Initiatives

13.4. Hurel Corporation

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerOrgan Typeance

13.4.4. Recent Initiatives

13.5. BEOnChip S.L

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerOrgan Typeance

13.5.4. Recent Initiatives

13.6. BioIVT

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerOrgan Typeance

13.6.4. Recent Initiatives

13.7. SynVivo Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerOrgan Typeance

13.7.4. Recent Initiatives

13.8. 4Dcell

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerOrgan Typeance

13.8.4. Recent Initiatives

13.9. TARA Biosystems (part of Valo Health)

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerOrgan Typeance

13.9.4. Recent Initiatives

13.10. Draper Laboratory

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerOrgan Typeance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The organ-on-a-chip market size is expected to increase from USD 227.40 million in 2025 to USD 3,448.33 million by 2034.

The organ-on-a-chip market is expected to grow at a compound annual growth rate (CAGR) of around 35.27% from 2025 to 2034.

The major players in the organ-on-a-chip market include Nortis Inc., AxoSim Inc., Organovo Holdings Inc., Hurel Corporation, BEOnChip S.L, BioIVT, SynVivo Inc., 4Dcell, TARA Biosystems (part of Valo Health), Draper Laboratory, Microfluidic ChipShop GmbH, Kirkstall Ltd., BiomimX S.r.l., AlveoliX AG , and Tara Biosystems Inc.

The driving factors of the organ-on-a-chip market are the accurate preclinical testing can decrease the rate of drug candidate failure in later clinical trials, even saving time and resources. These systems provide precise control over the experimental environment, permitting the study of dynamic processes such as tissue interfaces, stress, and cell-cell interactions that are challenging to replicate in other settings.

North America region will lead the global organ-on-a-chip market during the forecast period 2025 to 2034.